19: Extended spectrum beta-lactamase urinary tract infections during pregnancy




Objectives


Extended spectrum beta-lactamases (ESBLs) are enzymes produced by gram-negative bacilli that result in resistance against most antibiotics. We sought to evaluate the epidemiology and impact of ESBL urinary tract infections (UTIs) during pregnancy.




Methods


We performed a case control study comparing outcomes in pregnant women with optimally treated ESBL UTIs, sub-optimally treated ESBL UTIs, and non-ESBL UTIs from 2012-2014. Sub-optimal treatment was defined as treatment without carbapenems or post-treatment negative urine culture. For those with ESBL UTIs, we identified antecedent infections, prior antibiotic use, and the treatment course.




Methods


We performed a case control study comparing outcomes in pregnant women with optimally treated ESBL UTIs, sub-optimally treated ESBL UTIs, and non-ESBL UTIs from 2012-2014. Sub-optimal treatment was defined as treatment without carbapenems or post-treatment negative urine culture. For those with ESBL UTIs, we identified antecedent infections, prior antibiotic use, and the treatment course.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Selective serotonin reuptake inhibitors for depression in pregnancy
  2. Immune activation enhances epithelial nerve growth in provoked vestibulodynia
  3. 6: T cell activation in south african HIV-exposed infants linked to ochratoxin exposure
  4. 16: Uropathogens and antibiotic resistance temporal trends among pregnant women: updated assessment and comparison from 2005-2014

Stay updated, free articles. Join our Telegram channel
Tags:
May 2, 2017 | Posted by in GYNECOLOGY | Comments Off on 19: Extended spectrum beta-lactamase urinary tract infections during pregnancy

Full access? Get Clinical Tree
Get Clinical Tree app for offline access